These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 34401226)

  • 1. Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome.
    Zoulikha M; Xiao Q; Boafo GF; Sallam MA; Chen Z; He W
    Acta Pharm Sin B; 2022 Feb; 12(2):600-620. PubMed ID: 34401226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small interfering RNA for cancer treatment: overcoming hurdles in delivery.
    Charbe NB; Amnerkar ND; Ramesh B; Tambuwala MM; Bakshi HA; Aljabali AAA; Khadse SC; Satheeshkumar R; Satija S; Metha M; Chellappan DK; Shrivastava G; Gupta G; Negi P; Dua K; Zacconi FC
    Acta Pharm Sin B; 2020 Nov; 10(11):2075-2109. PubMed ID: 33304780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design.
    Qiao Q; Liu X; Yang T; Cui K; Kong L; Yang C; Zhang Z
    Acta Pharm Sin B; 2021 Oct; 11(10):3060-3091. PubMed ID: 33977080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal.
    Eljack S; David S; Faggad A; Chourpa I; Allard-Vannier E
    Int J Pharm X; 2022 Dec; 4():100126. PubMed ID: 36147518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blockade of programmed death-ligand 1 attenuates indirect acute lung injury in mice through targeting endothelial cells but not epithelial cells].
    Sun B; Li X; Zheng G; Dong T; Li Y; Li H; Yan Y; Bai J; Xu S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jan; 31(1):37-43. PubMed ID: 30707867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological drug and drug delivery-mediated immunotherapy.
    Xiao Q; Li X; Li Y; Wu Z; Xu C; Chen Z; He W
    Acta Pharm Sin B; 2021 Apr; 11(4):941-960. PubMed ID: 33996408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolyplexes comprising imidazole/imidazolium lipophosphoramidate, histidinylated polyethyleneimine and siRNA as efficient formulation for siRNA transfection.
    Gonçalves C; Berchel M; Gosselin MP; Malard V; Cheradame H; Jaffrès PA; Guégan P; Pichon C; Midoux P
    Int J Pharm; 2014 Jan; 460(1-2):264-72. PubMed ID: 24225347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NLRC3 Participates in Inhibiting the Pulmonary Inflammatory Response of Sepsis-Induced Acute Lung Injury.
    Li R; Zhao Y; Zhang X; Yang L; Zou X
    Immunol Invest; 2023 Nov; 52(5):567-582. PubMed ID: 37139806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?
    Conte G; Costabile G; Baldassi D; Rondelli V; Bassi R; Colombo D; Linardos G; Fiscarelli EV; Sorrentino R; Miro A; Quaglia F; Brocca P; d'Angelo I; Merkel OM; Ungaro F
    ACS Appl Mater Interfaces; 2022 Feb; 14(6):7565-7578. PubMed ID: 35107987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems.
    Rezaee M; Oskuee RK; Nassirli H; Malaekeh-Nikouei B
    J Control Release; 2016 Aug; 236():1-14. PubMed ID: 27317365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant.
    Hafner AM; Corthésy B; Merkle HP
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1386-99. PubMed ID: 23751781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
    J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
    de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
    Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo gene silencing (with siRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage-induced, neutrophil-mediated septic acute lung injury.
    Lomas-Neira JL; Chung CS; Wesche DE; Perl M; Ayala A
    J Leukoc Biol; 2005 Jun; 77(6):846-53. PubMed ID: 15695553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene silencing of receptor-interacting protein 2 protects against cigarette smoke-induced acute lung injury.
    Dong J; Liao W; Tan LH; Yong A; Peh WY; Wong WSF
    Pharmacol Res; 2019 Jan; 139():560-568. PubMed ID: 30394320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy.
    Merckx P; De Backer L; Van Hoecke L; Guagliardo R; Echaide M; Baatsen P; Olmeda B; Saelens X; Pérez-Gil J; De Smedt SC; Raemdonck K
    Acta Biomater; 2018 Sep; 78():236-246. PubMed ID: 30118853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in microRNA delivery.
    Zhang Y; Wang Z; Gemeinhart RA
    J Control Release; 2013 Dec; 172(3):962-74. PubMed ID: 24075926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.